GO:0004051 arachidonate 5-lipoxygenase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004051 describes the catalytic activity of arachidonate 5-lipoxygenase (ALOX5), which converts arachidonic acid and oxygen into leukotriene A4 (LTA4) and water.
• ALOX5 is the rate-limiting enzyme in leukotriene biosynthesis and requires calcium, ATP, and the accessory protein FLAP for efficient cellular activity.
• The enzyme is regulated at multiple levels, including gene expression, calcium-dependent membrane translocation, and phosphorylation.
• ALOX5 activity is implicated in inflammatory diseases, cancer, and osteoarthritis, with recent studies linking it to ferroptosis and JAK2/STAT3 signaling.
• Intrinsic 5-lipoxygenase activity can influence cell migration and adherence in mantle cell lymphoma, suggesting roles beyond inflammation.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential to dissect the causal roles of ALOX5 and its pathway components.
Description
Arachidonate 5-lipoxygenase activity (GO:0004051) is a molecular function that catalyzes the conversion of arachidonic acid and molecular oxygen to leukotriene A4 (LTA4) and water. This enzymatic step is the committed and rate-limiting reaction in the biosynthesis of leukotrienes, a family of potent lipid mediators involved in inflammation and immune responses. The enzyme responsible, arachidonate 5-lipoxygenase (ALOX5), is a non-heme iron-containing dioxygenase that requires calcium and ATP for its activity and interacts with the 5-lipoxygenase-activating protein (FLAP) for efficient substrate presentation. Understanding this activity is crucial for researchers studying inflammatory diseases, cancer, and other pathological conditions where leukotrienes play a role.
arachidonate 5-lipoxygenase activity At A Glance
| GO ID | GO:0004051 |
|---|---|
| GO term | arachidonate 5-lipoxygenase activity |
| Ontology | molecular_function |
| Synonym | 5-lipoxygenase activity, leukotriene A4 synthase, LTA synthase activity |
| Major function | Catalyzes the conversion of arachidonic acid to leukotriene A4 |
| Reaction | (5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 = H2O + leukotriene A4 |
| Cofactors | Non-heme iron, calcium, ATP |
| Accessory protein | FLAP (5-lipoxygenase-activating protein) |
What Is GO:0004051?
According to the Gene Ontology, GO:0004051 arachidonate 5-lipoxygenase activity is defined as the catalysis of the reaction: (5Z,8Z,11Z,14Z)-eicosatetraenoate + O2 = H2O + leukotriene A4. In simpler terms, it is the enzyme activity that inserts a molecular oxygen into arachidonic acid at the C-5 position, forming the unstable intermediate leukotriene A4, which is then converted to other leukotrienes.
Why Is arachidonate 5-lipoxygenase activity Important in Cell Biology?
Arachidonate 5-lipoxygenase activity is critically important because it initiates the synthesis of leukotrienes, which are key mediators of inflammation, allergy, and host defense. Dysregulation of this activity is associated with a wide range of diseases, including asthma, arthritis, cancer, and cardiovascular disorders. Moreover, recent research has uncovered roles for ALOX5 in ferroptosis and cell migration, expanding its significance beyond traditional inflammatory pathways.
• Rate-limiting step in leukotriene biosynthesis, which drives inflammatory responses.
• Implicated in asthma, allergic rhinitis, and other inflammatory diseases.
• Associated with cancer progression, including mantle cell lymphoma.
• Linked to osteoarthritis progression via ferroptosis and JAK2/STAT3 signaling.
• Potential therapeutic target for anti-inflammatory and anti-cancer drugs.
• Regulated by calcium, ATP, and phosphorylation, making it a dynamic signaling node.
• Expressed in various cell types, including leukocytes and cancer cells.
• Its activity can be modulated by FLAP inhibitors and other small molecules.
Molecular Mechanism of arachidonate 5-lipoxygenase activity
Substrate binding and activation
In simple terms: The enzyme grabs arachidonic acid and oxygen to start the reaction.
ALOX5 binds arachidonic acid and molecular oxygen in a calcium-dependent manner. Calcium binding induces membrane translocation, where the enzyme encounters its substrate. The enzyme also requires ATP for optimal activity, although the exact role of ATP is not fully understood.
Catalytic mechanism
In simple terms: The enzyme uses iron to add oxygen to arachidonic acid, forming LTA4.
ALOX5 contains a non-heme iron in its active site that cycles between Fe2+ and Fe3+ states. The reaction involves stereospecific hydrogen abstraction at C-5 of arachidonic acid, followed by oxygen insertion to form 5-hydroperoxyeicosatetraenoic acid (5-HPETE), which is subsequently dehydrated to leukotriene A4.
Role of FLAP and cellular organization
In simple terms: A helper protein called FLAP presents the substrate to the enzyme.
FLAP (5-lipoxygenase-activating protein) is an integral membrane protein that binds arachidonic acid and facilitates its transfer to ALOX5. This interaction is essential for efficient leukotriene synthesis in cells. FLAP inhibitors block leukotriene production and have been explored as anti-inflammatory drugs.
Regulation by phosphorylation and calcium
In simple terms: The enzyme's activity is turned on and off by chemical signals.
ALOX5 activity is regulated by phosphorylation at multiple serine residues, which affects its subcellular localization and catalytic activity. Calcium influx triggers translocation of ALOX5 from the cytosol to the nuclear envelope, where it colocalizes with FLAP and other enzymes.
Helical remodeling and conformational changes
In simple terms: The enzyme changes shape to become more active.
Recent studies have shown that helical remodeling in ALOX5 augments its activity in the synthesis of proinflammatory mediators. This structural flexibility allows the enzyme to adapt to different substrates and regulatory cues.
Key Genes Involved in GO:0004051 arachidonate 5-lipoxygenase activity
The following genes and proteins are key players in arachidonate 5-lipoxygenase activity and its associated pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ALOX5 | Catalyzes the conversion of arachidonic acid to LTA4 | Central enzyme; target for knockout and point mutation studies |
| ALOX5AP (FLAP) | Activates ALOX5 by presenting arachidonic acid | Essential for leukotriene synthesis; knockout reduces inflammation |
| LTA4H | Converts LTA4 to LTB4 | Downstream enzyme; modulates leukotriene profiles |
| LTC4S | Converts LTA4 to LTC4 | Involved in cysteinyl leukotriene synthesis |
| PLA2G4A | Releases arachidonic acid from membranes | Provides substrate for ALOX5 |
| COX2 (PTGS2) | Competes for arachidonic acid | Cross-talk with prostaglandin pathway |
| JAK2 | Signaling kinase upstream of STAT3 | Linked to ALOX5-mediated ferroptosis in osteoarthritis |
| STAT3 | Transcription factor | Mediates ALOX5 effects on ferroptosis |
| GPX4 | Glutathione peroxidase | Inhibits ferroptosis; interacts with ALOX5 pathway |
| NFKB1 | Transcription factor | Regulates ALOX5 expression |
| MAPK1 (ERK2) | Kinase | Phosphorylates ALOX5 and regulates activity |
| MAPK14 (p38) | Kinase | Phosphorylates ALOX5 and regulates activity |
| PRKAA1 (AMPK) | Energy sensor | May regulate ALOX5 via phosphorylation |
| CASP3 | Apoptosis effector | Cleaves ALOX5 in some contexts |
| HIF1A | Hypoxia-inducible factor | Regulates ALOX5 expression under hypoxia |
| SP1 | Transcription factor | Activates ALOX5 promoter |
| CREB1 | Transcription factor | Regulates ALOX5 expression |
| NRF2 (NFE2L2) | Oxidative stress response | Modulates ALOX5 and ferroptosis |
How Is arachidonate 5-lipoxygenase activity Regulated?
Arachidonate 5-lipoxygenase activity is regulated at multiple levels. Transcriptionally, the ALOX5 gene is controlled by transcription factors such as SP1, CREB1, and NFKB1. Post-translationally, ALOX5 is phosphorylated by kinases including MAPK1 (ERK2), MAPK14 (p38), and PRKAA1 (AMPK), which affect its localization and activity. Calcium binding is required for membrane translocation and interaction with FLAP. Additionally, the enzyme is subject to feedback inhibition by its products and can be modulated by redox status. Recent studies have linked ALOX5 activity to ferroptosis via the JAK2/STAT3 pathway, indicating crosstalk with cell death signaling.
arachidonate 5-lipoxygenase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ALOX5 | Asthma, arthritis, cancer | Knockout mouse or human cell lines |
| ALOX5AP | Inflammatory diseases | Knockout or knockdown models |
| ALOX5 | Osteoarthritis | Knockout or overexpression in chondrocytes |
| ALOX5 | Mantle cell lymphoma | Knockdown or knockout in lymphoma cell lines |
| ALOX5 | Ferroptosis | Point mutation of catalytic residues |
Inflammatory diseases
ALOX5 activity is a key driver of leukotriene synthesis, which contributes to asthma, allergic rhinitis, and rheumatoid arthritis. Inhibitors of ALOX5 or FLAP are used to reduce leukotriene production in these conditions.
Cancer
ALOX5 is overexpressed in various cancers, including mantle cell lymphoma, where its intrinsic activity regulates cell migration and adherence. Targeting ALOX5 may reduce cancer cell dissemination and improve outcomes.
Osteoarthritis
Recent evidence shows that inhibiting ALOX5 expression ameliorates osteoarthritis progression by suppressing ferroptosis via the JAK2/STAT3 signaling pathway. This highlights a novel role for ALOX5 in joint degeneration.
Ferroptosis and oxidative stress
Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death, in which ALOX5 activity contributes to lipid peroxidation. Modulating ALOX5 may influence ferroptosis in degenerative diseases.
From arachidonate 5-lipoxygenase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ALOX5 knockout reduce leukotriene production? | ALOX5 knockout cell line or mouse |
| How does a specific point mutation affect catalytic activity? | Point mutation knock-in of ALOX5 |
| Can overexpression of ALOX5 drive inflammation? | Overexpression cell model |
| What is the role of FLAP in ALOX5 activity? | ALOX5AP knockout or knockdown |
| Does ALOX5 regulate ferroptosis in osteoarthritis? | Knockout or overexpression in chondrocytes |
| How does ALOX5 activity affect cell migration? | Knockdown in mantle cell lymphoma cells |
How to Study the arachidonate 5-lipoxygenase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| HPLC-based assay | 5-HPETE or LTA4 formation | Enzyme kinetics and inhibitor testing |
| LC-MS/MS lipidomics | Leukotriene levels | Pathway flux in cells and tissues |
| RNA-seq | ALOX5 mRNA expression | Transcriptional regulation studies |
| Western blot | ALOX5 protein and phosphorylation | Post-translational modification analysis |
| Fluorescence microscopy | Subcellular localization | Calcium-induced translocation |
| CRISPR knockout | Loss of ALOX5 function | Causal role in leukotriene synthesis |
| CRISPR point mutation | Specific catalytic residue changes | Structure-function studies |
| Overexpression | Gain of function | Disease modeling |
Enzyme activity assays
ALOX5 activity can be measured using spectrophotometric or HPLC-based assays that detect the formation of 5-HPETE or LTA4 from arachidonic acid. These assays are typically performed with cell lysates or purified enzyme and require calcium and ATP.
Gene expression analysis
RNA-seq and qPCR can quantify ALOX5 mRNA levels in response to stimuli or genetic perturbations. Western blotting is used to assess protein expression and phosphorylation status.
Metabolite profiling
LC-MS/MS-based lipidomics can measure leukotriene products (LTB4, LTC4, etc.) to infer ALOX5 activity in cells and tissues. This approach is valuable for studying pathway flux and drug effects.
Imaging and subcellular localization
Fluorescence microscopy with GFP-tagged ALOX5 can visualize its translocation to the nuclear envelope upon calcium stimulation. This method helps study the spatiotemporal regulation of the enzyme.
How CRISPR Can Be Used to Study GO:0004051 arachidonate 5-lipoxygenase activity
Knockout
CRISPR-Cas9 knockout of ALOX5 or ALOX5AP eliminates enzyme activity and leukotriene production, providing a clean background to study downstream effects. Knockout cell lines are valuable for validating drug targets and understanding inflammatory pathways.
Point Mutation
Introducing point mutations in the catalytic domain of ALOX5 (e.g., iron-binding residues) can dissect the enzymatic mechanism and distinguish catalytic activity from non-enzymatic functions. Such models are useful for studying substrate specificity and inhibitor binding.
Knock-in
Knock-in of tagged ALOX5 (e.g., GFP or FLAG) allows real-time tracking of protein localization and interaction partners without altering endogenous regulation. This approach is ideal for imaging and proteomic studies.
Overexpression
Overexpression of ALOX5 in cell lines or animal models can mimic pathological states where the enzyme is upregulated, such as cancer or osteoarthritis. These models help test whether increased activity is sufficient to drive disease phenotypes.
How EDITGENE Supports arachidonate 5-lipoxygenase activity Research
Researchers studying arachidonate 5-lipoxygenase activity-related genes often need to determine whether a candidate gene is causally involved in leukotriene synthesis, inflammation, or ferroptosis. EDITGENE provides custom CRISPR gene editing services to create precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for arachidonate 5-lipoxygenase activity research.
Frequently Asked Questions About arachidonate 5-lipoxygenase activity
What is arachidonate 5-lipoxygenase activity?
It is the enzyme activity that converts arachidonic acid to leukotriene A4, encoded by the GO term GO:0004051.
What genes are involved in arachidonate 5-lipoxygenase activity?
The primary gene is ALOX5, but ALOX5AP (FLAP), LTA4H, LTC4S, and PLA2G4A are also involved in the pathway.
What is the role of ALOX5 in inflammation?
ALOX5 initiates leukotriene synthesis, which drives inflammatory responses in asthma, arthritis, and other diseases.
How is arachidonate 5-lipoxygenase activity regulated?
It is regulated by calcium, ATP, phosphorylation, and interactions with FLAP, as well as transcriptional control.
What diseases are associated with arachidonate 5-lipoxygenase activity?
Asthma, allergic rhinitis, rheumatoid arthritis, cancer, and osteoarthritis have been linked to ALOX5 activity.
Can CRISPR be used to study arachidonate 5-lipoxygenase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect ALOX5 function.
What is the reaction catalyzed by arachidonate 5-lipoxygenase?
It catalyzes the conversion of arachidonic acid and O2 to leukotriene A4 and water.
What are the synonyms for arachidonate 5-lipoxygenase activity?
Common synonyms include 5-lipoxygenase activity, leukotriene A4 synthase, and LTA synthase activity.
How can I measure arachidonate 5-lipoxygenase activity?
Activity can be measured using HPLC-based assays, LC-MS/MS lipidomics, or by detecting leukotriene products.
What is the role of FLAP in arachidonate 5-lipoxygenase activity?
FLAP (ALOX5AP) presents arachidonic acid to ALOX5 and is essential for efficient leukotriene synthesis.
Conclusion
Arachidonate 5-lipoxygenase activity (GO:0004051) is a central enzymatic function in leukotriene biosynthesis, with broad implications for inflammation, cancer, and degenerative diseases. Understanding its regulation and cellular roles requires robust experimental models, and CRISPR-based approaches offer precise tools to manipulate ALOX5 and its pathway components. EDITGENE provides comprehensive gene editing services to support such research, from knockout to knock-in and screening.
References
- 1. Rådmark O. 2002. Arachidonate 5-lipoxygenase.. Prostaglandins Other Lipid Mediat 68-69:211-34 PMID: 12432920
- 2. Li C et al.. 2021. Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death.. Autophagy 17(4):948-960 PMID: 32186434
- 3. Gallegos EM et al.. 2022. Helical remodeling augments 5-lipoxygenase activity in the synthesis of proinflammatory mediators.. J Biol Chem 298(9):102282 PMID: 35863431
- 4. Peters-Golden M et al.. 2003. 5-lipoxygenase and FLAP.. Prostaglandins Leukot Essent Fatty Acids 69(2-3):99-109 PMID: 12895592
- 5. Ford-Hutchinson AW et al.. 1994. 5-Lipoxygenase.. Annu Rev Biochem 63:383-417 PMID: 7979243
- 6. Zou F et al.. 2026. Inhibiting Arachidonate-5-lipoxygenase expression ameliorates osteoarthritis progression by suppressing ferroptosis via the JAK2/STAT3 signaling pathway.. Free Radic Biol Med 246:334-349 PMID: 41581577
- 7. Rådmark O et al.. 2007. 5-Lipoxygenase: regulation of expression and enzyme activity.. Trends Biochem Sci 32(7):332-41 PMID: 17576065
- 8. Xia C et al.. 2021. Intrinsic 5-lipoxygenase activity regulates migration and adherence of mantle cell lymphoma cells.. Prostaglandins Other Lipid Mediat 156:106575 PMID: 34116165
